| ARES |
Report |
Adjusted/Realized EPS |
BEAT |
pred ~$1.38 vs. cons $1.30 |
HIGH |
| ARES |
Report |
Total Management Fees |
BEAT |
pred ~$1.14B vs. cons $1.10B |
MEDIUM |
| ARES |
Report |
Fee-Related Earnings (FRE) |
BEAT |
pred ~$505M vs. cons ~$495M |
MEDIUM |
| ARES |
Guide |
FY2026 FRE margin expansion |
BETTER |
guide ~150bps vs. cons ~100bps (FY2026) |
MEDIUM |
| ARES |
Guide |
FY2026 Realized income growth |
UNCHANGED |
guide ~22% vs. cons ~21% (FY2026) |
LOW |
| ARES |
Guide |
2028 wealth-channel cumulative fundraising target |
UNCHANGED |
guide ~$125B vs. cons ~$125B (by 2028) |
MEDIUM |
| ARES |
Guide |
Direct-lending credit quality / non-accrual trend commentary |
UNKNOWN |
guide ~stable-to-modestly-higher non-accruals (~1.5-2.0%) vs. cons expectation of ~2.0-2.4% (Q3 2026 outlook) |
LOW |
| ARES |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.0% |
— |
LOW |
| ARES |
Return |
5-day cumulative residual |
+0.4% (FADE) |
Much of the 'good news' (the >$50M realized performance income vs $16M prior year) was pre-announced on July 10 and is already in consensus/price, capping upside surprise on the print itself. Headline FRE/fee growth should beat, driving an initial positive pop, but the realized-income tailwind is non-recurring and analysts will normalize it out of forward estimates; combined with ARCC's read-through (rising non-accruals, negative net originations, declining NAV) raising the bar for ARES' own credit commentary, and no incremental raise to FY26 targets (management merely reaffirms 16-20% FRE CAGR / 20-25% RI CAGR), out-period estimate revisions are likely to be flat-to-slightly-down once the one-off is stripped out. That dynamic, plus lingering ambiguity on the Leonard Green deal (no signed agreement, could cut either way), points to an initial pop that fades over the week rather than sustained follow-through. |
LOW |